ACE

Tag: Decision-making

  • Understanding the Debate on AI in Electronic Health Records

    Understanding the Debate on AI in Electronic Health Records

    Background

    Artificial Intelligence (AI) refers to the use of computer algorithms to process data and make decisions, ultimately streamlining administrative processes. In healthcare, AI is being increasingly integrated with Electronic Health Records (EHRs)—digital systems that store and manage patient health information, such as medical history and diagnoses. By 2021, almost 80% of office-based physicians and virtually all non-federal acute care hospitals had implemented an EHR system. As part of this widespread adoption, various AI applications in EHRs are beginning to emerge. So far, the main functions of AI in EHRs include managing datasets of patient health information, identifying patterns in health data, and using these patterns to predict health outcomes and recommend pathways for treatment. 

    Arguments in Favor of AI in EHRs

    The use of AI in EHRs presents opportunities to improve healthcare by increasing efficiency as well as supplying administrative support. Supporters of AI integration argue that it can significantly improve diagnostic accuracy. AI-integrated EHR systems can analyze vast amounts of patient data, flagging potential issues that might otherwise be overlooked by human clinicians. Machine learning algorithms can identify patterns across multiple cases and recommend diagnoses or treatments based on evidence from similar cases. Proponents contend that by reducing human error and providing real-time insights, AI could support doctors in making more accurate and quick decisions, leading to better patient outcomes.

    Proponents of AI in EHRs also argue that AI has the potential to significantly reduce healthcare inequities by providing better access and more personalized care for underserved populations. AI-powered tools can identify at-risk patients early by analyzing complex data, including demographic and behavioral factors, and help prioritize interventions for those who need it most. Additionally, AI can bridge communication gaps for patients facing language barriers or low health literacy, ensuring they receive clear and relevant information about their health. Supporters also suggest that AI’s ability to reduce human biases in clinical decision-making, such as disparities in pain assessment or treatment recommendations, could lead to fairer, more equitable healthcare outcomes for all.

    From the workforce perspective, supporters argue that AI integration in EHRs has the ability to significantly reduce physician burnout by streamlining the documentation process. With the increasing time spent on EHR tasks, AI-driven tools like voice-to-text transcription, automated note generation, and data entry can cut down the time physicians devote to administrative duties. For instance, one 2023 study reported that AI integration in health records led to a 72% reduction in documentation time, equating to approximately 3.3 hours saved per week per clinician. This allows doctors to spend more time on direct patient care and less on paperwork, which supporters contend will improve job satisfaction and reduce stress.

    Arguments Against AI in EHRs

    While some argue that AI in EHRs will lead to more accurate and equitable healthcare, others raise concerns regarding data bias, privacy, and transparency. Critics of AI integration argue that modern legal frameworks lack adequate safeguards for individuals’ health data, leaving sensitive information vulnerable to breaches. For example, data collected by AI tools may be hacked or gathered without consent for marketing purposes. Additionally, certain genetics testing companies that operate without sufficient legal oversight may sell customer data to pharmaceutical and biotechnology companies.

    Moreover, some critics share concerns about whether AI integration in EHRs aligns with standards for informed consent. Informed consent is a key ethical principle that ensures patients are fully informed and in control of decisions regarding their healthcare. It includes elements such as the patient’s ability to understand and make decisions about their diagnoses, treatment options, and any risks involved. Ethical responsibility dictates that consent should be specific, voluntary, and clear. The rise of AI in healthcare applications has increased concerns about whether patients are fully aware of how their data is used, the risks of procedures, and potential errors in AI-driven treatments. Autonomy principles state that patients have the right to be informed about their treatment process, the privacy of their data, and the potential risks of AI-related procedures, such as errors in programming. Critics say that patients must be more informed about how AI is integrated into health records systems in order for them to truly provide informed consent. 

    Another significant ethical concern in the use of AI and machine learning (ML) in healthcare is algorithmic bias, which can manifest in racial, gender, and socioeconomic disparities due to flaws in algorithm design. Such biases may lead to misdiagnosis or delayed treatments for underrepresented groups and exacerbate inequities in access to care. To address this, advocates push for the prioritization of diverse training data that reflects demographic factors. They hold that regular evaluations are necessary to ensure that AI models consistently remain fair over time, upholding the principles of justice and equity. 

    Future Outlook

    Building on the potential of AI in healthcare, H.R. 238, introduced on January 7, 2025, proposes that AI systems be authorized to prescribe medications if they are approved by the Food and Drug Administration (FDA) and if the state where they operate permits their use for prescribing. This bill represents a significant step in integrating AI into clinical practices, going beyond data management to reshape how medications are prescribed and managed. The arguments for and against H.R. 238 mirror the debate around AI integration in EHRs; while proponents of the bill argue that AI could enhance patient safety, reduce errors, and alleviate clinician burnout, critics highlight concerns regarding the loss of human judgment, data privacy, and the potential for AI to reinforce biases in healthcare. As AI continues to play a central role in healthcare, bills like H.R. 238 spark important discussions about AI’s ethical, practical, and legal implications in clinical decision-making.

    Summary

    In conclusion, the integration of AI into EHRs has forced medical stakeholders to balance a need for improvements in accuracy and efficiency with a concern for medical ethics and patient privacy. On one hand, AI can support more accurate diagnoses, enhance patient care, and help reduce the burnout faced by healthcare providers. Additionally, AI may contribute to reducing healthcare inequities by providing better access and more personalized care, especially for underserved populations. However, the implementation of AI also raises concerns regarding data privacy, algorithmic bias, and informed consent, suggesting a need for more careful implementation and oversight. As AI’s presence in healthcare settings continues to expand, addressing these concerns will be key to ensuring it benefits patients and healthcare providers alike.

  • Trump’s Tariffs: Key Updates and Ongoing Debate

    Trump’s Tariffs: Key Updates and Ongoing Debate

    One of President Trump’s myriad “first-day” promises, the plan to leverage tariffs against Canada, Mexico, and China drew attention on the campaign trail. Two weeks into his second term, the campaign promise came to fruition via three consecutive executive orders, sparking economic debate and what some are calling a trade war with neighboring countries. 

    The Executive Orders

    On February first, the White House released an emergency memo announcing new tariffs as a means to combat “the extraordinary threat posed by illegal aliens and drugs”. The declaration alluded to executive orders from the same day which invoked the International Emergency Economic Powers Act (IEEPA) to impose tariffs on Canada, Mexico, and China. Collectively, these orders levied 25% tariffs on all goods from Canada and Mexico and a 10% tariff on all goods from China. The first order carves out a smaller 10% tariff on energy resources imported from Canada to limit domestic energy shortages.

    Diplomatic Standoff and Temporary Delay

    Just before the tariffs were set to take effect, Mexican President Claudia Sheinbaum and Canadian Prime Minister Justin Trudeau negotiated a 30-day delay, agreeing to several conditions. The 30-day window sets a tight deadline for implementing the following measures, with the potential for future U.S. tariffs lingering in the case of failed implementation:

    Canada:

    • Appointing a Fentanyl Czar: Canada will designate a high-level official responsible for coordinating efforts to combat fentanyl production and distribution.
    • Designation of Drug Cartels as Terrorist Organizations: This move aims to enhance legal frameworks for tackling organized crime.
    • Intelligence Sharing and Funding: Canada will implement an intelligence directive targeting fentanyl and organized crime, supported by substantial funding.
    • Border Security Enhancements: Canada has pledged to bolster its border security measures to prevent illegal crossings and drug smuggling.

    Mexico:

    • Deployment of National Guard: Mexico will send 10,000 National Guard troops to its northern border to prevent drug trafficking and illegal immigration.
    • Cooperation on Weapons Trafficking: Mexico will work jointly with the U.S. to curb the trafficking of weapons into Mexico.

    China did not negotiate a delay, and instead retaliated immediately with its own tariffs on American energy and agricultural imports. China also filed an official dispute in the World Trade Organization.

    During negotiations for the 30-day-delay, Canada also retaliated with its own tariffs on U.S. goods. On February 4th, Prime Minister Trudeau implemented a CA$155 billion tariff package that will impact myriad products including steel and plastic, household appliances, and coffee. Mexico has not yet proposed retaliatory tariffs. 

    Prospective Impacts

    The Trump administration’s use of tariffs is not new; in his first term, President Trump levied considerable tariffs on steel and aluminum imports, impacting China, India, the European Union, and other trade partners. However, President Trump’s recent executive orders have drawn increased attention for their novel scope. This is the first time in American history that a sitting President has invoked IEEPA to leverage tariffs, bypassing the formal investigation process required under other tariff-related laws like Section 232. Supporters emphasize that the use of IEEPA allows President Trump to act more efficiently in light of the pressing opioid crisis, while critics warn that using IEEPA to implement tariffs risks unchecked executive authority. 

    Economically, some experts warn that this round of tariffs could raise consumer prices significantly more than the tariffs from the last Trump administration due to their expanded scope, targeting of consumer goods, and ongoing inflation. A report from the Tax Foundation estimates that tariffs will function as a hidden tax, potentially costing households hundreds of dollars annually. Senate Minority Leader Chuck Schumer called the tariffs “the beginning of a golden age of higher costs for American families”, warning that they would strain relations with allies and worsen supply chain issues. On the other hand, some argue that Trump’s tariff strategy has already succeeded in forcing Canada and Mexico to the negotiating table, leading to unprecedented commitments to address border security and the drug trade. They emphasize that the proposed tariffs were a strategic move to force cooperation from neighboring countries on pressing issues, despite the short-term economic cost. 

    Will the Tariffs Actually Be Imposed?

    While the 30-day delay provides an opportunity for Canada and Mexico to fulfill their commitments, President Trump has stated that he fully intends to impose tariffs if they fail to act decisively. Moreover, on February 13th, President Trump signed a memo calling for research on retaliatory tariffs, signaling that the White House is preparing to impose additional tariffs on nations like Canada and China that initially retaliated with tariffs of their own.